Eton Pharmaceuticals (ETON) Current Assets (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Current Assets of $60.6 million for Q4 2025, down 15.86% sequentially from $72.0 million in Q3 2025, and up 47.68% YoY from $41.0 million in Q4 2024.
Eton Pharmaceuticals (ETON) Current Assets (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Current Assets for 9 years, with the latest figure at $60.6 million in Q4 2025.
- Quarterly Current Assets rose 47.68% year-over-year to $60.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $60.6 million (up 47.68% YoY) and the FY2025 annual result came in at $60.6 million, up 47.68% from the prior year.
- Current Assets eased to $60.6 million in Q4 2025 per ETON's latest filing, from $72.0 million in the prior quarter.
- Over five years, Current Assets peaked at $72.0 million in Q3 2025 and troughed at $16.4 million in Q3 2022.
- A 5-year average of $32.7 million and a median of $26.6 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets plunged 38.06% in 2022, then surged 169.1% in 2025.
- Over 5 years, Current Assets stood at $23.6 million in 2021, then retreated by 15.25% to $20.0 million in 2022, then soared by 34.17% to $26.8 million in 2023, then soared by 52.84% to $41.0 million in 2024, then surged by 47.68% to $60.6 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $60.6 million, $72.0 million, and $68.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.22 Bn |
| 10 | Eton Pharmaceuticals | 1.68 Bn | 1.65 Bn | 25.41 Mn | 68.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.60 Mn |
| Dec 31, 2025 | 60.58 Mn |
| Sep 30, 2025 | 72.00 Mn |
| Jun 30, 2025 | 68.44 Mn |
| Mar 31, 2025 | 49.96 Mn |
| Dec 31, 2024 | 41.02 Mn |
| Sep 30, 2024 | 29.75 Mn |
| Jun 30, 2024 | 25.43 Mn |
| Mar 31, 2024 | 24.26 Mn |
| Dec 31, 2023 | 26.84 Mn |
| Sep 30, 2023 | 27.16 Mn |
| Jun 30, 2023 | 26.33 Mn |
| Mar 31, 2023 | 19.12 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Sep 30, 2022 | 16.42 Mn |
| Jun 30, 2022 | 19.78 Mn |
| Mar 31, 2022 | 18.75 Mn |
| Dec 31, 2021 | 23.60 Mn |
| Sep 30, 2021 | 25.86 Mn |
| Jun 30, 2021 | 29.08 Mn |